The FDA approved Tamoxifen for prevention of primary breast cancer in 1998 and it approved Raloxifene more recently in 2007. Primary breast cancer prevention is an additional use of both drugs. Tamoxifen is widely used to treat early and advanced hormone-receptor positive breast cancer and Raloxifene had been primarily used for the prevention and treatment […]
Entries Tagged as 'Health Care Products'
March 25th, 2015 · 1 Comment
Tags: Food and Drug Administration · Health Care Consumer Alert · Health Care Products · Health Care Reform · Medical Error Alert · Medical Ethics · Medical Malpractice · Medical Mistakes · Medication Errors · Patient Education · Patient Safety · Pharmaceutical Fraud